Please assess the completion status of the following clinical trial:

Trial Title: Prolotherapy Versus Steroids for Thumb Carpo-metacarpal Joint Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>45~* Ability to make follow-up visits over the 6 month protocol~* Ability to give informed consent~* Eaton grade 2-3 thumb carpo-metacarpal joint osteoarthritis with pain over 3/10 on visual analogue scale with symptoms present greater then 6 months.~Exclusion Criteria:~* Recent trauma to the hand or wrist or fractures eeen on radiographs~* Eaton grade 1, or 4 joints affected~* Metabolic bone disease~* Recent systemic or localized infection (within last 2 weeks)~* History of rheumatologic disease~* Allergies to injected solutions~* Thumb carpo-metacarpal joint injections in the prior 6 months.

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Prolotherapy group (Type: EXPERIMENTAL): Subjects randomized to this arm will receive injection(s) of 10% dextrose solution in the affected thumb joint.
- Corticosteroid Group (Type: ACTIVE_COMPARATOR): Subjects randomized to this arm will receive injection(s) of betamethasone solution in the affected thumb joint.

Based on this trial design, predict the completion outcome and termination type (if applicable).